BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
ID: 353071Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353071

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-016.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for the development of next-generation devices aimed at recording and modulating the human central nervous system (CNS). This initiative encourages interdisciplinary collaborations and focuses on significant risk clinical studies that require Investigational Device Exemptions (IDE) from the FDA, emphasizing real-time data synchronization and participant safety. The funding, anticipated to be around $10 million per year, will support approximately 5 to 7 awards, with a project plan that includes a Needs Assessment, an Intellectual Property Strategy, and a Long-term Care Plan for Patients. Interested applicants must submit their proposals by January 28, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-NS-24-016.html
    The National Institutes of Health (NIH), through its BRAIN Initiative, is offering funding opportunities for the development of next-generation devices to record and modulate the human central nervous system (CNS) under the announcement RFA-NS-24-016. The initiative encourages interdisciplinary collaborations, particularly those involving diverse teams to enhance innovation and address health disparities. Funding aims to support projects focusing on significant risk (SR) clinical studies requiring Investigational Device Exemptions (IDE) from the FDA, with an emphasis on real-time data synchronization and participant safety. This cooperative agreement mechanism encompasses two phases: EG3 for regulatory activities and UH3 for conducting clinical studies, with specific milestones that track progress. Applicants must present a robust plan for enhancing diversity and submit various required attachments, including a Needs Assessment, an Intellectual Property Strategy, and a Long-term Care Plan for Patients. The NIH is anticipated to provide $10 million per year to support around 5 to 7 awards. All projects must align with the BRAIN Initiative’s overarching goals to advance neurotechnology and improve understanding and treatment of CNS disorders.
    Similar Opportunities
    BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative to support the development of next-generation devices for recording and modulation in the human central nervous system. This initiative aims to facilitate translational activities and small clinical studies focused on therapeutic and diagnostic devices for CNS disorders, particularly those requiring Investigational Device Exemptions (IDE) for significant risk studies. The program emphasizes milestone-driven cooperative agreements, collaboration among diverse research teams, and the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to promote equitable access in research. With an annual budget of $10 million available for approximately 5 to 7 awards, interested applicants can find more information and apply starting April 29, 2024, by contacting NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System," aimed at enhancing technologies for recording neural activity and addressing significant challenges in neuroscience research. This initiative seeks applications focused on optimizing existing or emerging technologies through iterative testing with end users, with the goal of improving network recording capabilities and developing tools for circuit manipulation that can be validated in vivo. The funding, anticipated at $10 million per year for 15-20 awards, requires applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research, with submissions due by January 20, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative to support the development of innovative recording and modulation technologies for diagnosing and treating central nervous system (CNS) diseases. The initiative aims to advance technologies from proof of concept to readiness for first-in-human studies, encouraging diverse, team-based applications that integrate various domains of expertise. This funding opportunity, with an award ceiling of $750,000 and a total budget of approximately $8 million for 5-7 awards, requires applicants to submit a Plan for Enhancing Diverse Perspectives and several key attachments. Interested parties should note that the application submission period begins on April 29, 2024, and closes on January 28, 2027. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-031.html.
    BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative, titled "New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)." This initiative aims to support proof-of-concept testing and the development of innovative neurotechnologies that can enhance the understanding of brain circuit dynamics and facilitate transformative neuroscience research. The program encourages high-risk, high-impact projects that integrate diverse scientific domains and require applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. The total estimated funding available is $10 million annually, with plans to support 15-20 awards over a maximum project period of three years. Interested applicants must adhere to strict submission guidelines, and the application deadline is January 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for exploratory research using invasive neural recording and stimulating technologies in the human brain. This initiative aims to assemble diverse, multidisciplinary teams to investigate high-impact questions in human neuroscience, focusing on establishing feasibility and proof-of-principle for future invasive studies while addressing clinical and ethical considerations. The NIH plans to commit approximately $6 million to fund multiple awards, with each application budget capped at $700,000 for direct costs per year over a maximum project period of three years. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for September 19, 2025.
    BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for innovative concepts and early-stage research focused on recording and modulation technologies in the nervous system (R21). This initiative invites applications that propose unique and untested ideas aimed at enhancing the capabilities of neural activity recording or modulation, with a strong emphasis on interdisciplinary collaboration and the inclusion of diverse perspectives through a required Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to fund approximately 10 awards annually, with individual project budgets capped at $400,000 over a maximum three-year period, and applications are due by June 15, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-23-001.html.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for research on the ethical implications of advancements in neurotechnology and brain science, designated as R21 Clinical Trial Optional grants. This initiative invites multi-disciplinary teams to explore critical ethical issues related to brain research, including topics such as brain imaging, data privacy, and informed consent, with the aim of fostering diverse collaborations and addressing significant ethical challenges in the field. The total funding available is $2 million annually over three years, supporting up to eight new awards, with individual project budgets capped at $275,000 for a two-year period. Interested applicants should note that the application period opens on September 11, 2024, and closes on October 9, 2026; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)" aimed at exploring the ethical dimensions of neuroscience research. This initiative encourages multidisciplinary teams to address core ethical issues such as informed consent, data privacy, and health disparities, emphasizing the importance of inclusive research practices. Funding is available for both exploratory projects under R21 and larger research grants under R01, with an anticipated budget of $3 million per year for up to eight awards. Interested applicants must submit their proposals by October 9, 2026, and are required to include a Plan for Enhancing Diverse Perspectives (PEDP) to integrate diverse viewpoints in their research. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)" aimed at developing and validating innovative tools to measure and synchronize human behaviors with brain activity. This initiative seeks to support a multidisciplinary approach, integrating fields such as neurobiology, engineering, and artificial intelligence, with a focus on creating tools that can accurately link behavioral data to brain activity. Approximately $10 million is available for funding, with an anticipated selection of 8-10 awards, and applications must adhere to specific guidelines, including a Plan for Enhancing Diverse Perspectives (PEDP) and neuroethics considerations. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for January 22, 2025.
    BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the BRAIN Initiative, aimed at developing and validating novel tools to analyze cell-specific and circuit-specific processes in the brain. This initiative seeks proposals that focus on creating innovative technologies to enhance the understanding of complex neural behaviors and interactions, particularly tools that are non-invasive and applicable across various model organisms. The program is critical for advancing research in brain function and disorders, with an estimated funding total of $8 million to support 6-9 awards, and applications are due by May 7, 2024. Interested applicants must submit a Plan for Enhancing Diverse Perspectives (PEDP) and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.